Results 221 to 230 of about 67,859 (329)

Regulation of Activation-induced Fas (CD95/Apo-1) Ligand Expression in T Cells by the Cyclin B1/Cdk1 Complex [PDF]

open access: hybrid, 2004
Ralph Torgler   +6 more
openalex   +1 more source

Isoliquiritigenin Promotes the Repair of High Uric Acid‐Induced Vascular Injuries

open access: yesSmart Medicine, Volume 4, Issue 2, June 2025.
High uric acid‐induced vascular injuries are always accompanied with hyperuricemia, for which seeking for effective safety drugs is an urgent and crucial problem that needs to be solved. Here, we have successfully screened isoliquiritigenin out from multiplex traditional Chinese medicine monomers in promoting the repair of high uric acid‐induced ...
Hongyan Zhou   +7 more
wiley   +1 more source

GGCT Inhibits Ferroptosis in PTC Cells by Upregulating p53 Through RPS15A

open access: yesCancer Science, Volume 116, Issue 6, Page 1592-1603, June 2025.
Our results showed that γ‐glutamine cyclotransferase (GGCT) knockdown in PTC cells inhibited GSH synthesis, promoted the malignant accumulation of malondialdehyde (MDA) and reactive oxygen species (ROS), and finally promoted cell ferroptosis. In vivo experiments showed that Pro‐GA, a specific inhibitor of GGCT, inhibited the subcutaneous tumorigenesis ...
Hui‐min Zhang   +9 more
wiley   +1 more source

Optimization of Immunotherapy Strategies Based on Spatiotemporal Heterogeneity of Tumour‐Associated Tissue‐Resident Memory T Cells

open access: yesImmunology, Volume 175, Issue 2, Page 123-133, June 2025.
The tumour microenvironment (TME) and tumour evolution stage lead to temporal and spatial heterogeneity in tumour‐resident macrophages (TRMs), affecting their phenotype and function across different stages and tumour types. While TRMs infiltration is often linked to positive immunotherapy responses and prognosis, some subtypes may negatively impact ...
Yile Shang   +10 more
wiley   +1 more source

Identification of differentially expressed genes in oral squamous cell carcinoma (OSCC): Overexpression of NPM, CDK1 and NDRG1 and underexpression of CHES1 [PDF]

open access: bronze, 2005
Joseph Tung‐Chieh Chang   +10 more
openalex   +1 more source

The p53-targeting human phosphatase hCdc14A interacts with the Cdk1/cyclin B complex and is differentially expressed in human cancers [PDF]

open access: gold, 2006
Michelle T. Paulsen   +6 more
openalex   +3 more sources

Omaveloxolone Suppresses Cell Growth and Causes Cell Cycle Arrest by Downregulating CDC20 Expression in Glioblastoma Cells Both In Vitro and In Vivo

open access: yesJournal of Cellular and Molecular Medicine, Volume 29, Issue 11, June 2025.
ABSTRACT Omaveloxolone is a synthetic oleanane triterpene with considerable antitumor activity. It induces human glioblastoma (GBM) cell death in vitro and in vivo, but the underlying mechanism remains to be determined. In this study, GBM cell lines (GBM8401 and U‐87 MG cells) were exposed to different concentrations of omaveloxolone (0, 600, 800 and ...
Kuan‐Ting Lee   +4 more
wiley   +1 more source

Plk1 docking to GRASP65 phosphorylated by Cdk1 suggests a mechanism for Golgi checkpoint signalling [PDF]

open access: green, 2005
Christian Preisinger   +5 more
openalex   +1 more source

HAND2-AS1 plays a tumor-suppressive role in hepatoblastoma through the negative regulation of CDK1

open access: yesHeliyon
Objective: Hepatoblastoma (HB) is the most commonly seen pediatric liver malignancy. The preliminary experiment of our research group found that cyclin dependent kinase 1 (CDK1) was upregulated in HB.
Keke Chen   +7 more
doaj  

The Efficacy of Hellebrigenin Against Nasopharyngeal Carcinoma Cells: The Molecular and Bioinformatic Analysis

open access: yesJournal of Cellular and Molecular Medicine, Volume 29, Issue 11, June 2025.
ABSTRACT Nasopharyngeal carcinoma (NPC) is a unique cancer type originating from the nasopharynx. To investigate novel strategies for improving prognosis and reducing the adverse effects of current treatments, this study examined the efficacy of hellebrigenin.
Hsin‐Yu Ho   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy